Soarafenib Soranib Sorafenib 200 Mg Tablets, Cipla, 30Tablets

₹ 1,100/Box

Packaging Size30Tablets
BrandSoranib
CompositionSoarafenib
ManufacturerCipla
Prescription/Non prescriptionPrescription
FormTablet
Strength200mg
Packging TypeBox
AvailabilityIn Stock
30 TabletsSorafenib Tablets Ip 200 Mg SoranibEach Film Coated Tablet Contains: Sorafenib Tosylate Ip Equivalent To Sorafenib.. 200 MgColours: Red Oxide Of Iron, Titanium Dioxide Ip & Yellow Oxide Of Iron. Dosage & Administration: As Directed By The Oncologist. Storage: Store Below 30 °C. Protect From Light

Find products similar to Soarafenib Soranib Sorafenib 200 Mg Tablets, Cipla, 30Tablets

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromThane
ShippingAs per delivery location

Product Image

Soarafenib Soranib Sorafenib 200 Mg Tablets, Cipla, 30Tablets-1Soarafenib Soranib Sorafenib 200 Mg Tablets, Cipla, 30Tablets-2Soarafenib Soranib Sorafenib 200 Mg Tablets, Cipla, 30Tablets-3

Interested in this product?Get Latest Price from the seller

About the Company

GST Registration Date
02-03-2022
Legal Status of Firm
Partnership
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
1.5 - 5 Cr
IndiaMART Member Since
Mar 2022
GST
27AAJFE4835C1ZK
Import Export Code (IEC)
AAJFE*****

Incepted in the year 2022, “Eskay Healthcare” is a distinguished wholesaler offering an enormous consignment of Pharmaceutical Tablets, Pharmaceutical Capsules, Pharmaceutical Injection,Cricare medicine,nephrology drug,anti cacer medicines,virology drug,hepatitis c...etc.We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers. For our accomplishment story, we are grateful to our Miss Purva, whose continual backing and direction have been useful to us for attaining exponential development in the current market.